Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study

BACKGROUND: Nephrotoxicity and ototoxicity are clinically significant dose-related adverse effects associated with second-line anti-tubercular injectables drugs (aminoglycosides and capreomycin) used during intensive phase of treatment of multi-drug resistant tuberculosis (MDR-TB) patients. Data are...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibeshi, Workineh, Sheth, Anandi N., Admasu, Addisu, Berha, Alemseged Beyene, Negash, Zenebe, Yimer, Getnet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533713/
https://www.ncbi.nlm.nih.gov/pubmed/31122273
http://dx.doi.org/10.1186/s40360-019-0313-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533713/
https://www.ncbi.nlm.nih.gov/pubmed/31122273
http://dx.doi.org/10.1186/s40360-019-0313-y

Ejemplares similares